Academic Journal

Novel Non-Congeneric Derivatives of the Choline Kinase Alpha Inhibitor ICL-CCIC-0019

التفاصيل البيبلوغرافية
العنوان: Novel Non-Congeneric Derivatives of the Choline Kinase Alpha Inhibitor ICL-CCIC-0019
المؤلفون: Ning Wang, Diana Brickute, Marta Braga, Chris Barnes, Haonan Lu, Louis Allott, Eric O. Aboagye
المصدر: Pharmaceutics; Volume 13; Issue 7; Pages: 1078
بيانات النشر: Multidisciplinary Digital Publishing Institute
سنة النشر: 2021
المجموعة: MDPI Open Access Publishing
مصطلحات موضوعية: choline kinase alpha (CHKA) inhibitor, ICL-CCIC-0019, prodrug, PSMA, targeted drug delivery, PIK4CB
الوصف: Choline kinase alpha (CHKA) is a promising target for the development of cancer therapeutics. We have previously reported ICL-CCIC-0019, a potent CHKA inhibitor with high cellular activity but with some unfavorable pharmacological properties. In this work, we present an active analogue of ICL-CCIC-0019 bearing a piperazine handle (CK146) to facilitate further structural elaboration of the pharmacophore and thus improve the biological profile. Two different strategies were evaluated in this study: (1) a prodrug approach whereby selective CHKA inhibition could be achieved through modulating the activity of CK146, via the incorporation of an ε-(Ac) Lys motif, cleavable by elevated levels of histone deacetylase (HDAC) and cathepsin L (CTSL) in tumour cells; (2) a prostate-specific membrane antigen (PSMA) receptor targeted delivery strategy. Prodrug (CK145) and PSMA-targeted (CK147) derivatives were successfully synthesized and evaluated in vitro. While the exploitation of CK146 in those two strategies did not deliver the expected results, important and informative structure-activity relationships were observed and have been reported.
نوع الوثيقة: text
وصف الملف: application/pdf
اللغة: English
Relation: Biologics and Biosimilars; https://dx.doi.org/10.3390/pharmaceutics13071078
DOI: 10.3390/pharmaceutics13071078
الاتاحة: https://doi.org/10.3390/pharmaceutics13071078
Rights: https://creativecommons.org/licenses/by/4.0/
رقم الانضمام: edsbas.8BAE2FCE
قاعدة البيانات: BASE
الوصف
DOI:10.3390/pharmaceutics13071078